Prostaglandins and their analogs in eyelash-growth treatments will undergo safety assessment by the EU’s Scientific Committee on Consumer Safety, following a request from the European Commission.
The SCCS specifically is asked to consider the safety of isopropyl cloprostenate (CAS 157283-66-4) and ethyl tafluprostamide or DDDE (CAS...







